MedDataX Logo

Chronic Obstructive Pulmonary Disease Patient Preferences Survey

NCT ID: NCT02970422

Last Updated: 2020-12-24

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-11-30

Study Completion Date

2018-12-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to distribute a questionnaire created for individuals living with chronic obstructive pulmonary disease (COPD) to assess their activities, participation, and healthcare and COPD-related research priorities. The data collected will be compared across diagnosed COPD stages and disease severity to determine the extent to which adults with COPD participate in the listed activities and identify their primary research and healthcare related priorities. The questionnaire was originally developed based on past research then verified by a panel of COPD and participation experts; as well as, individuals living with COPD in the form of focus groups. The questionnaire will now be administered to 200 individuals living COPD (50 in each GOLD stage) at three sites across Montreal where clinical data for each participant will be available. This phase will help establish the reliability of the questionnaire.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Disease, Chronic Obstructive

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Survey Priorities Activities Participation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Quartile 1 [Mild]

Patient Survey

Intervention Type OTHER

Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.

Quartile 2 [Moderate]

Patient Survey

Intervention Type OTHER

Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.

Quartile 3 [Severe]

Patient Survey

Intervention Type OTHER

Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.

Quartile 4 [Very Severe]

Patient Survey

Intervention Type OTHER

Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Patient Survey

Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical diagnosis of COPD
* English or French speaking
* Patient at one of the three participating sites with medical chart

Exclusion Criteria

* No diagnosis of COPD by a healthcare professional
* Unable to communicate in English or French
* Unable to provide informed consent
* No medical chart information at one of the three participating sites
Minimum Eligible Age

40 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role collaborator

McGill University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dennis Jensen, Ph.D.

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dennis Jensen, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

McGill University

Shane N Sweet, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

McGill University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Montreal Chest Institute of the McGill University Health Center (MUHC)

Montreal, Quebec, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Informed Consent Form

View Document

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Related Links

Access external resources that provide additional context or updates about the study.

http://www.mcgill.ca/cerpl/

Clinical Exercise and Respiratory Physiology Laboratory (CERPL)

http://exercisepsych.research.mcgill.ca/

Theories and Interventions in Exercise and Health Psychology (TIE) Laboratory

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

15-203-MUHC

Identifier Type: -

Identifier Source: org_study_id